Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MOBILITY- Metformin for Overweight & OBese ChILdren and Adolescents With BIpolar Spectrum Disorders Treated With Second-Generation AntipsYchotics

NCT02515773 is registered in ClinicalTrials.gov with Melissa Delbello as lead sponsor.

NCT NCT02515773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02515773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MOBILITY- Metformin for Overweight & OBese ChILdren and Adolescents With BIpolar Spectrum Disorders Treated With Second-Generation AntipsYchotics
Lead sponsor
Melissa Delbello
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2015
Completion date
June 30, 2023
Enrollment
1,565 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder